About this trial
LSCSI is a Hub\&Spoke project with the main aim to improve the outcome of patients with cardiogenic shock in Lower Silesia region, Poland. It consists of one "hub" which is Wroclaw University Hospital and eleven "spokes" which are eleven cardiology departments situated in Lower Silesian Voivodeship. The consortium have unified protocol defining which cardiogenic shock patient and when should be transferred to the "hub" for enhanced treatment options including durable mechanical circulatory support or heart transplant. The "hub" have 7/24 Shock Team on-site supplied with a protocol how to proceed with "spoke" transferred patients including decision making on which mechanical circulatory support implant with subsequent de-escalation or escalation pathway.
Eligibility criteria
Qualifiers
Fulfilled definition of cardiogenic shock
Age 18 - 60 years
Shock duration below 24 hours
Disqualifiers
History of cardiac arrest with anoxemic brain injury
Irreversible multiorgan failure
End stage of chronic diseases other than heart failure
Neoplastic disease
Trial design
Treatments tested in this trial
- Structured treatment of cardiogenic shock patients